Technical Director
ICON plc
Summary
PhD with postdoctoral fellowship in Clinical Chemistry and at least 3 years of clinical laboratory technical director experience in a clinical laboratory setting. Must have a NYS CoQ and certification by recognized board like the ABCC, HCLD and others.
Job description
What You Will Do
- Oversee all activities within the Clinical Chemistry subspecialty laboratory operations in FMG.
- Sign-out cases needing certified specialty director review, including serum and urine protein electrophoresis and LCMSMS reports.
- Oversee QA/QI/PI in Clinical Chemistry Laboratory.
- Insure regulatory and compliance requirements including PT, certifications, QMS, management reviews and others to ensure quality testing and results, patient safety, and maintenance of laboratory accreditation.
- Train laboratory personnel on SOPs, proficiencies and maintenance of competencies.
- Sign off on validation/verification plans on test/assay development.
- Help troubleshoot technical issues and solutioning in Clinical Chemistry.
- Participate in global laboratory tasks as well as business development assignments as an SME.
Your Profile
PhD with postdoctoral fellowship in Clinical Chemistry and at least 3 years of clinical laboratory technical director experience in a clinical laboratory setting. Must have a NYS CoQ and certification by recognized board like the ABCC, HCLD and others.
Requirements
- PhD with postdoctoral fellowship in Clinical Chemistry
- At least 3 years of clinical laboratory technical director experience in a clinical laboratory setting
- Must have a NYS CoQ
- Certification by recognized board like the ABCC, HCLD and others
Benefits
- Competitive base salary
- Performance related incentives
- Medical, Dental & Vision
- Retirement and pension plans
- Life assurance and disability coverage
- Employee assistance programmes
- Learning and development opportunities
Company overview
ICON plc is a global leader in clinical research and healthcare intelligence, founded in Dublin, Ireland in 1990. As one of the world's largest contract research organizations (CROs), ICON provides comprehensive outsourced development services to pharmaceutical, biotechnology, and medical device companies worldwide. The company operates in 55 countries with approximately 41,900 employees, offering end-to-end solutions that span the entire product development lifecycle. ICON's service portfolio includes clinical research services, adaptive trials, biosimilars, commercialization and outcomes consulting, medical imaging, laboratory services, and strategic support for traditional and digital health technologies. The company specializes in therapeutic areas such as oncology, cardiovascular diseases, central nervous system disorders, rare diseases, and women's health. With its 2021 acquisition of PRA Health Sciences, ICON significantly expanded its capabilities and market position, becoming a dominant force in the global CRO industry. The company is publicly traded on NASDAQ under the ticker ICLR and reported $8.28 billion in revenue for 2024.